The ROE as of September 2024 (TTM) for Reata Pharmaceuticals, Inc. (RETA) is 19.32%

According to Reata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 19.32%. This represents a change of -105.76% compared to the average of -335.65% of the last 4 quarters.

Reata Pharmaceuticals, Inc. (RETA) Historical ROE (quarterly & annually)

How has RETA ROE performed in the past?

The mean historical ROE of Reata Pharmaceuticals, Inc. over the last ten years is 61.36%. The current 19.32% ROE has changed -68.51% with respect to the historical average. Over the past ten years (40 quarters), RETA's ROE was at its highest in in the March 2019 quarter at 632.41%. The ROE was at its lowest in in the September 2022 quarter at -1700.42%.

Reata Pharmaceuticals, Inc. (RETA) ROE by Quarter and Year

Discovering the peaks and valleys of Reata Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reata Pharmaceuticals, Inc. (RETA) Average ROE

How has RETA ROE performed in the past?

The current ROE of Reata Pharmaceuticals, Inc. (RETA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Reata Pharmaceuticals, Inc. (RETA) ROE vs. Peers

How is RETA’s ROE compared to its peers?

Reata Pharmaceuticals, Inc.’s ROE is less than Sarepta Therapeutics, Inc. (5.17%), greater than Mirati Therapeutics, Inc. (-81.10%), less than Krystal Biotech, Inc. (13.36%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), less than PTC Therapeutics, Inc. (0%), less than Madrigal Pharmaceuticals, Inc. (57.03%), greater than CureVac N.V. (-95.61%), greater than Vir Biotechnology, Inc. (-56.93%), greater than Propanc Biopharma, Inc. (-30.93%), less than Viking Therapeutics, Inc. (70.39%), greater than Terns Pharmaceuticals, Inc. (-15.05%), greater than Akero Therapeutics, Inc. (-39.58%), greater than null (-29.56%),

Build a custom stock screener for Reata Pharmaceuticals, Inc. (RETA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reata Pharmaceuticals, Inc. (RETA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.